back to homepage



Invited Lecture

Discovery and Development of Antiviral Therapeutics for Emerging and Neglected Viral Infections

Dr. Tomas Cihlar
Vice President of Virology at Gilead Sciences, San Francisco Bay Area, USA

Tomas Cihlar holds a position of Vice President, Virology, at Gilead. After earning his PhD in Biochemistry at the Institute of Organic Chemistry and Biochemistry in Prague, Czech Republic in 1994, Tomas joined Gilead as Postdoctoral Fellow and later as Research Scientist, supporting the discovery and development of antivirals including HIV medications such as tenofovir, one of the leading HIV drugs, and its combinations. At Gilead, Tomas is currently overseeing research on all antivirals.





Plenary Lecture

Substituted or hetero-fused 7-deazapurine nucleoside cytostatics with complex mechanism of action

Prof. Michal Hocek
Institute of Organic Chemistry and Biochemistry of the CAS, Prague, Czech Republic

Michal Hocek was born in Benesov (Czechoslovakia) in 1969. He graduated with MSc. from the Prague Institute of Chemical Technology in 1993, received his Ph.D. in 1996 at the Czech Academy of Sciences under supervision of Prof. Antonín Holý and performed his postdoc at the Université Catholique de Louvain in Belgium with Prof. Leon Ghosez. In 1998 he joined the Institute of Organic Chemistry and Biochemistry in Prague where he became Group leader since 2003. Since 2011, he has a joint appointment (part-time) as a professor at the Dept. of Organic Chemistry at Charles University in Prague. He received the Alfred Bader Award, the Wichterle Premium and the Praemium Academiae and is an elected member of the Learned Society of the Czech Republic. His research interests include the use of organic synthesis and organometallic chemistry in modification of biomolecules, chemistry of nucleosides, nucleotides and nucleic acids, medicinal chemistry, bioorganic and bioconjugate chemistry, and chemical biology. More info:


Plenary Lecture

Inhibitors of topoisomerases: from antibacterial to anticancer agents

Assoc. prof. Dr. Janez Ilaš
Faculty of Pharmacy, University of Ljubljana, Slovenia

Janez Ilaš studied Pharmacy at the Faculty of Pharmacy, University of Ljubljana, where he obtained a PhD in 2008. He has been an Associate Professor of Pharmaceutical Chemistry at the Faculty of Pharmacy, University of Ljubljana, since 2013. His research interests are the design, synthesis, and evaluation of small-molecule enzyme inhibitors for different therapeutic areas, including infectious diseases and cancer. He has authored more than 60 papers, and has been involved in academic and EU-funded drug discovery programs (EU FP7 Project MAREX and EU H2020 MSCA-ITN INTEGRATE).





Plenary Lecture

In silico Design of Chemical Modulators for Chromatin Biology

Prof. Yoel Rodríguez
Department of Natural Sciences, Hostos Community College of CUNY, New York, USA


Plenary Lecture

The Role(s) of Dipeptidyl Peptidase III in Humans

Prof. Dr. Sanja Tomić
Head of Laboratory for Protein Biochemistry and Molecular Modelling, Ruđer Bošković Institute, Zagreb, Croatia


GUARANT International spol. s r. o.
Na Pankráci 17, 140 21  Prague 4, Czech Republic
Phone: +420 284 001 444, Fax: +420 284 001 448

© 2018 GUARANT International spol. s r. o.